Search

Your search keyword '"Sylvie Behillil"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Sylvie Behillil" Remove constraint Author: "Sylvie Behillil"
77 results on '"Sylvie Behillil"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.

3. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates

4. Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions

5. Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients

6. Bidirectional Human–Swine Transmission of Seasonal Influenza A(H1N1)pdm09 Virus in Pig Herd, France, 2018

7. SARS-CoV-2 viral dynamics in non-human primates.

8. Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine

9. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

10. Detection of human bocavirus-1 in both nasal and stool specimens from children under 5 years old with influenza-like illnesses or diarrhea in Gabon

11. Detection and Quantification of Influenza Virus Defective Viral Genomes from NGS Datasets Obtained after RT or RT-PCR Product Sequencing

12. Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission

13. Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV

14. Saliva for molecular detection of SARS‐CoV ‐2 in pre‐school and school‐age children

15. Clinical and virological data of the first cases of COVID-19 in Europe: a case series

16. Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre study analysis by age-group, vaccine brand and time since vaccination, I-MOVE-COVID-19 and ECDC networks, July–August 2021

17. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

18. A virus-encoded microRNA contributes to evade innate immune response during SARS-CoV-2 infection

20. Bidirectional Human–Swine Transmission of Seasonal Influenza A(H1N1)pdm09 Virus in Pig Herd, France, 2018

21. Virus, épidémies et réseaux de surveillance de la grippe

22. A new SARS-CoV-2 variant poorly detected by RT-PCR on nasopharyngeal samples, with high lethality

23. Travel-driven emergence and spread of SARS-CoV-2 lineage B.1.620 with multiple VOC-like mutations and deletions in Europe

24. High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in healthcare workers: results of the CoV-CONTACT prospective cohort

25. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020

26. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

27. SARS-CoV-2 viral dynamics in non-human primates

28. Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients

29. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

30. Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020

31. Estimation of influenza-attributable burden in primary care from season 2014/2015 to 2018/2019, France

32. Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021

33. Early phylodynamics analysis of the COVID-19 epidemic in France

34. A New SARS-CoV-2 Variant Poorly Detected by RT-PCR on Nasopharyngeal Samples, with High Lethality

35. First Cases of Coronavirus Disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

36. Viral dynamic modeling of SARS-CoV-2 in non-human primates

37. Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020

38. Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children

39. Detection and Quantification of Influenza Virus Defective Viral Genomes from NGS Datasets Obtained after RT or RT-PCR Product Sequencing

40. Hydroxychloroquine in the treatment and prophylaxis of SARS-CoV-2 infection in non- human primates

41. Introductions and early spread of SARS-CoV-2 in France

42. SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors

43. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020

44. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

45. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020

46. A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study

47. Étude de la réponse humorale anti-SARS-CoV-2 et de la persistance virale dans une cohorte de 96 patients avec rhumatisme inflammatoire chronique (PR et SpA) sous immunomodulateurs, infectés par le SARS-CoV-2

48. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus

49. Oseltamivir Resistance in Severe Influenza A(H1N1)pdm09 Pneumonia and Acute Respiratory Distress Syndrome: A French Multicenter Observational Cohort Study

50. Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care

Catalog

Books, media, physical & digital resources